Krystal Biotech
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell KRYS and other ETFs, options, and stocks.About KRYS
Krystal Biotech, Inc. operates as a biotechnology company, which engages in developing and commercializing pharmaceutical products. It offers the product, VYJUVEK.
KRYS Key Statistics
Stock Snapshot
As of today, Krystal Biotech(KRYS) shares are valued at $199.97. The company's market cap stands at 5.8B, with a P/E ratio of 29.98.
On 2025-11-06, Krystal Biotech(KRYS) stock moved within a range of $195.76 to $202.94. With shares now at $199.97, the stock is trading +2.2% above its intraday low and -1.5% below the session's peak.
Trading activity shows a volume of 249.1K, compared to an average daily volume of 396.99K.
The stock's 52-week range extends from a low of $122.80 to a high of $212.98.
The stock's 52-week range extends from a low of $122.80 to a high of $212.98.
KRYS News
Krystal Biotech, Inc. recently reported third-quarter 2025 earnings, revealing net income of US$79.37 million and total revenue of US$97.8 million, reflecting s...
Krystal Biotech, Inc. ((KRYS)) has held its Q3 earnings call. Read on for the main highlights of the call. Elevate Your Investing Strategy: Take advantage of Ti...
Krystal Biotech, Inc. ( (KRYS) ) has released its Q3 earnings. Here is a breakdown of the information Krystal Biotech, Inc. presented to its investors. Elevate...
Analyst ratings
92%
of 12 ratingsMore KRYS News
Earnings Call Insights Krystal Biotech targets global expansion for VYJUVEK with launches in Germany, France, and Japan amid pipeline acceleration Nov. 03, 2025...
Note: This is an earnings call transcript. Content may contain errors. Image source: The Motley Fool. Monday, Nov. 3, 2025 at 8:30 a.m. ET CALL PARTICIPANTS Cha...
(RTTNews) - Krystal Biotech, Inc. (KRYS) announced a profit for its third quarter that Increased, from last year The company's earnings totaled $79.37 million,...
